Literature DB >> 2826638

The effect of phenolic glycolipid-1 from Mycobacterium leprae on the antimicrobial activity of human macrophages.

M A Neill1, S J Klebanoff.   

Abstract

Purified PGL-1 and dPGL from M. leprae can prevent bacterial killing by intact phagocytes and cell-free antimicrobial systems. Both glycolipids completely abolished the antimicrobial effect of the acetaldehyde-XO-Fe2+ system. Because the cytotoxicity of this system is inhibited by catalase, SOD, mannitol, and ethanol, but not by heated SOD or catalase, these data suggest that toxicity is due to OH. generated by the Haber-Weiss reaction. That the antimicrobial killing in the XO system is completely blocked by the addition of PGL-1 or dPGL suggests that these glycolipids can act as OH. scavengers. A modest protective effect against the cytotoxicity of the MPO-H2O2-halide system by both PGL-1 and dPGL was also observed. The antimicrobial activity of the MPO system was abolished with chloride, but not iodide, as the halide. The effect of the M. leprae-derived glycolipid on bacterial killing by intact phagocytes was examined. Two linking antibodies were used to bind the dPGL to a rapidly growing test organism, S. aureus, a murine IgM mAb specific for the terminal glycoside of PGL-1, and a rabbit IgG anti-mouse IgM which bound the staphylococcal protein A via its Fc region. Examination by transmission EM of human monocyte-derived macrophages which had ingested staphylococci either coated with both antibodies and dPGL, or coated only with the IgG and IgM antibodies, demonstrated the presence of bacteria in phagosomes of control and IFN-gamma-activated macrophages. Activation of the macrophage monolayers by pretreatment with IFN-gamma markedly increased their staphylocidal activity. When dPGL coated staphylococci were ingested, killing by both control and IFN-gamma-activated macrophages was completely blocked. These results, suggesting that PGL-1 can scavenge reactive oxygen species and prevent microbial death within the phagosome, may in part explain the intracellular survival of M. leprae in certain cell types.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2826638      PMCID: PMC2188820          DOI: 10.1084/jem.167.1.30

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  34 in total

1.  Viability of blood-borne Mycobacterium leprae.

Authors:  D J Drutz; S M O'Neill; L Levy
Journal:  J Infect Dis       Date:  1974-09       Impact factor: 5.226

2.  Role of iron and ethylenediaminetetraacetic acid in the bactericidal activity of a superoxide anion-generating system.

Authors:  H Rosen; S J Klebanoff
Journal:  Arch Biochem Biophys       Date:  1981-05       Impact factor: 4.013

3.  Ultrastructural and cytochemical changes induced by short and prolonged culture of human monocytes.

Authors:  J Breton-Gorius; J Guichard; W Vainchenker; J L Vilde
Journal:  J Reticuloendothel Soc       Date:  1980-03

4.  Differentiation of macrophages from normal human bone marrow in liquid culture. Electron microscopy and cytochemistry.

Authors:  D R Bainton; D W Golde
Journal:  J Clin Invest       Date:  1978-06       Impact factor: 14.808

5.  Adherence of lysostaphin to and penetration into human monocytes.

Authors:  P J van den Broek; L F Buys; R van Furth
Journal:  Scand J Immunol       Date:  1985-02       Impact factor: 3.487

6.  A serological test for leprosy with a glycolipid specific for Mycobacterium leprae.

Authors:  D B Young; T M Buchanan
Journal:  Science       Date:  1983-09-09       Impact factor: 47.728

7.  Serological activity of a characteristic phenolic glycolipid from Mycobacterium leprae in sera from patients with leprosy and tuberculosis.

Authors:  S J Brett; P Draper; S N Payne; R J Rees
Journal:  Clin Exp Immunol       Date:  1983-05       Impact factor: 4.330

8.  Bactericidal activity of a superoxide anion-generating system. A model for the polymorphonuclear leukocyte.

Authors:  H Rosen; S J Klebanoff
Journal:  J Exp Med       Date:  1979-01-01       Impact factor: 14.307

9.  Effect of normal and activated human macrophages on Toxoplasma gondii.

Authors:  S E Anderson; J S Remington
Journal:  J Exp Med       Date:  1974-05-01       Impact factor: 14.307

10.  Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.

Authors:  C F Nathan; H W Murray; M E Wiebe; B Y Rubin
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  24 in total

1.  Preliminary characterization of a Mycobacterium abscessus mutant in human and murine models of infection.

Authors:  T F Byrd; C R Lyons
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  FAD-sequestering proteins protect mycobacteria against hypoxic and oxidative stress.

Authors:  Liam K Harold; James Antoney; F Hafna Ahmed; Kiel Hards; Paul D Carr; Trevor Rapson; Chris Greening; Colin J Jackson; Gregory M Cook
Journal:  J Biol Chem       Date:  2018-12-19       Impact factor: 5.157

3.  Structural and functional characterization of the Pseudomonas hydroperoxide resistance protein Ohr.

Authors:  Jacob Lesniak; William A Barton; Dimitar B Nikolov
Journal:  EMBO J       Date:  2002-12-16       Impact factor: 11.598

Review 4.  Role of oxidants in microbial pathophysiology.

Authors:  R A Miller; B E Britigan
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

5.  Regulation of expression of major histocompatibility antigens by bovine macrophages infected with Mycobacterium avium subsp. paratuberculosis or Mycobacterium avium subsp. avium.

Authors:  D J Weiss; O A Evanson; D J McClenahan; M S Abrahamsen; B K Walcheck
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

6.  Inhibition of human lymphoproliferative responses by mycobacterial phenolic glycolipids.

Authors:  J J Fournie; E Adams; R J Mullins; A Basten
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

7.  Modulation of the cytokine response in human monocytes by mycobacterium leprae phenolic glycolipid-1.

Authors:  Claudia Manca; Blas Peixoto; Wladimir Malaga; Christophe Guilhot; Gilla Kaplan
Journal:  J Interferon Cytokine Res       Date:  2011-10-07       Impact factor: 2.607

8.  Mycobacterium leprae phenolglycolipid-1 expressed by engineered M. bovis BCG modulates early interaction with human phagocytes.

Authors:  Guillaume Tabouret; Catherine Astarie-Dequeker; Caroline Demangel; Wladimir Malaga; Patricia Constant; Aurélie Ray; Nadine Honoré; Nana Fatimath Bello; Esther Perez; Mamadou Daffé; Christophe Guilhot
Journal:  PLoS Pathog       Date:  2010-10-21       Impact factor: 6.823

9.  Chemical basis of rough and smooth variation in mycobacteria.

Authors:  J T Belisle; P J Brennan
Journal:  J Bacteriol       Date:  1989-06       Impact factor: 3.490

10.  MmpL8 is required for sulfolipid-1 biosynthesis and Mycobacterium tuberculosis virulence.

Authors:  Scott E Converse; Joseph D Mougous; Michael D Leavell; Julie A Leary; Carolyn R Bertozzi; Jeffery S Cox
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.